CN Patent
CN106163502B — 免疫抑制剂配方
Assigned to Novartis AG · Expires 2020-12-01 · 5y expired
What this patent protects
本发明关于一种包含辛波莫德、防潮剂及其他药物辅料的剂型,优选为用于立即释放的剂型,及用于生产该剂型的方法。
USPTO Abstract
本发明关于一种包含辛波莫德、防潮剂及其他药物辅料的剂型,优选为用于立即释放的剂型,及用于生产该剂型的方法。
Drugs covered by this patent
- Mayzent (SIPONIMOD) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.